サイズを選択してください
| 容量 | カタログ番号 | 在庫状況 | 単価 |
|---|---|---|---|
| 1 set | カートの在庫状況を確認する | ¥820,000 |
この商品について
Quality Segment
product line
MISSION®
concentration
≥5x108 VP/ml (via p24 assay)
technique(s)
capture ELISA: 5 x 108 TU/mL using p24
shipped in
dry ice
storage temp.
−70°C
General description
The MISSION LentiPlex Human shRNA Pooled Library 2.0 includes additional gene and clone coverage from the previously offered LentiPlex 1.0 Pooled Library . With the addition of 2.0, which consists of 5,000+ human genes and 20,000+ total clone coverage divided into 3 subpools, the complete whole-genome human library complete whole-genome human librarynow consists of over 125,000 shRNA constructs from the TRC collection targeting 20,000+ human genes. Each library is tested for shRNA representation before product release to ensure robust library coverage. The complete library is provided in ready-to-use lentiviral format at titers of at least 5 x 108 TU/ml via p24 assay and is pre-divided into sixteen subpools of approximately 6,000-8,000 shRNA constructs each. Amplification and sequencing primers are also provided for downstream target identification.
For more information including sample data and uses, please visit our LentiPlex Technical Detail Page.
Other Notes
Amplification and sequencing primers are also provided for downstream hit identification.
Deconvolution of shRNA Pools
Sigma′s deconvolution service lets you easily identify the genes that impact your pooled shRNA screen.
- Next-generation sequencing of clonesgives a precise number of individual clone occurrence within a pooled shRNA sample
- Comprehensive, reproducible results from pooled shRNA screens
- Statistically robust and information-rich data
Contact your local Sigma sales representative for more information or submit an inquiry to MISSION RNAi
Legal Information
1 of 1
当該品目 | |||
|---|---|---|---|
| product line MISSION® | product line MISSION® | product line MISSION® | product line MISSION® |
| technique(s) capture ELISA: 5 x 108 TU/mL using p24 | technique(s) capture ELISA: 5 x 108 TU/mL using p24 | technique(s) capture ELISA: 5 x 108 TU/mL using p24 | technique(s) capture ELISA: 5 x 108 TU/mL using p24 |
| concentration ≥5x108 VP/ml (via p24 assay) | concentration ≥5x108 VP/ml (via p24 assay) | concentration ≥5x108 VP/ml (via p24 assay) | concentration ≥5x108 VP/ml (via p24 assay) |
| storage temp. −70°C | storage temp. −70°C | storage temp. −70°C | storage temp. −70°C |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in dry ice |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
保管分類
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Cartagena Act Listed
cart
SHPH2-1SET:
jan
資料
RNAi Consortium (TRC): Collaborative effort among academic labs and biotech/pharma institutes advancing RNA interference research.
関連コンテンツ
創薬ターゲットとリードの特定に向けた確実なスクリーニングには、試験を経てプロセスに適合したハイスループット対応の試薬と機器が必要です。CRO、製薬企業またはバイオ企業における低分子および生物製剤のスクリーニングプロセス、ならびに治療安全性のための厳格な免疫原性試験に適したツールを選びましょう。
High-throughput reagents for drug target screening and immunogenicity testing.
Instructions
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| SHPH2-1SET | 04061833664025 |



